ZBIO logo

Zenas BioPharma, Inc. (ZBIO) Cash From Operations

Annual CFO:

-$119.67M-$89.14M(-292.00%)
December 31, 2024

Summary

  • As of today, ZBIO annual cash from operations is -$119.67 million, with the most recent change of -$89.14 million (-292.00%) on December 31, 2024.
  • During the last 3 years, ZBIO annual cash from operations has fallen by -$54.02 million (-82.29%).
  • ZBIO annual cash from operations is now -292.00% below its all-time high of -$30.53 million, reached on December 31, 2023.

Performance

1-Year Change

-292%

3-Year Change

-82.29%

5-Year Change

-82.29%

15-Year Change

-82.29%

ZBIO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.79%
ZBIO annual cash from operations is higher than 10.79% of companies in Healthcare sector

Range

All-Time High

-$30.53M
ZBIO annual cash from operations is currently -292.00% below its historical high of -$30.53 million

3-Year Low

-$119.67M
ZBIO annual cash from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ZBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 17, 2026
ZBIO next annual earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

Annual CFI

-$30.55M
ZBIO annual cash from investing is -$30.55 million

Annual CFF

$412.96M
ZBIO annual cash from financing is $412.96 million

Annual FCF

-$119.81M
ZBIO annual free cash flow is -$119.81 million

Annual CAPEX

$131.00K
ZBIO annual capital expenditures is $131.00 thousand

Quarterly CFO:

-$41.13M+$618.00K(+1.48%)
September 30, 2025

Summary

  • As of today, ZBIO quarterly cash from operations is -$41.13 million, with the most recent change of +$618.00 thousand (+1.48%) on September 30, 2025.
  • Over the past year, ZBIO quarterly cash from operations has dropped by -$10.07 million (-32.41%).
  • ZBIO quarterly cash from operations is now -229.14% below its all-time high of $31.85 million, reached on September 1, 2023.

Performance

3-Month Change

+1.48%

1-Year Change

-32.41%

3-Year Change

-

5-Year Change

-

ZBIO Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

8.14%
ZBIO quarterly cash from operations is higher than 8.14% of companies in Healthcare sector

Range

All-Time High

$31.85M
ZBIO quarterly cash from operations is currently -229.14% below its historical high of $31.85 million

3-Year Low

-$41.74M
ZBIO quarterly cash from operations is currently +1.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

Quarterly CFI

$40.04M
ZBIO quarterly cash from investing is $40.04 million

Quarterly CFF

$72.62M
ZBIO quarterly cash from financing is $72.62 million

Quarterly FCF

-$41.13M
ZBIO quarterly free cash flow is -$41.13 million

Quarterly CAPEX

$0.00
ZBIO quarterly capital expenditures is $0.00

TTM CFO:

-$158.47M-$10.07M(-6.78%)
September 30, 2025

Summary

  • As of today, ZBIO TTM cash from operations is -$158.47 million, with the most recent change of -$10.07 million (-6.78%) on September 30, 2025.
  • Over the past year, ZBIO TTM cash from operations has dropped by -$77.35 million (-95.36%).
  • ZBIO TTM cash from operations is now -1840.17% below its all-time high of -$8.17 million, reached on March 1, 2024.

Performance

3-Month Change

-6.78%

1-Year Change

-95.36%

3-Year Change

-

5-Year Change

-

ZBIO TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

8.14%
ZBIO TTM cash from operations is higher than 8.14% of companies in Healthcare sector

Range

All-Time High

-$8.17M
ZBIO TTM cash from operations is currently -1840.17% below its historical high of -$8.17 million

3-Year Low

-$158.47M
ZBIO TTM cash from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

TTM CFI

-$162.26M
ZBIO TTM cash from investing is -$162.26 million

TTM CFF

$76.29M
ZBIO TTM cash from financing is $76.29 million

TTM FCF

-$158.56M
ZBIO TTM free cash flow is -$158.56 million

TTM CAPEX

$92.00K
ZBIO TTM capital expenditures is $92.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ZBIO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-292.0%-32.4%-95.4%
3Y3 Years-82.3%--
5Y5 Years-82.3%--

ZBIO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-292.0%at low-229.1%+1.5%-1840.2%at low
5Y5-Year-292.0%at low-229.1%+1.5%-1840.2%at low
All-TimeAll-Time-292.0%at low-229.1%+1.5%-1840.2%at low

ZBIO Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$41.13M(+1.5%)
-$158.47M(-6.8%)
Jun 2025
-
-$41.74M(-12.7%)
-$148.41M(-7.8%)
Mar 2025
-
-$37.05M(+3.9%)
-$137.62M(-15.0%)
Dec 2024
-$119.67M
-$38.55M(-24.1%)
-$119.67M(-47.5%)
Sep 2024
-
-$31.06M(-0.3%)
-$81.12M(-345.3%)
Jun 2024
-
-$30.96M(-62.1%)
-$18.21M(-123.0%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$19.10M(-160.0%)
-$8.17M(+46.0%)
Dec 2023
-$30.53M(+53.5%)
-
-
Sep 2023
-
$31.85M(+252.3%)
-$15.13M(+67.8%)
Jun 2023
-
-$20.91M(+19.8%)
-$46.98M(-80.2%)
Mar 2023
-
-$26.06M
-$26.06M
Dec 2022
-$65.65M
-
-

FAQ

  • What is Zenas BioPharma, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. annual cash from operations year-on-year change?
  • What is Zenas BioPharma, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. quarterly cash from operations year-on-year change?
  • What is Zenas BioPharma, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. TTM cash from operations year-on-year change?

What is Zenas BioPharma, Inc. annual cash from operations?

The current annual cash from operations of ZBIO is -$119.67M

What is the all-time high annual cash from operations for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high annual cash from operations is -$30.53M

What is Zenas BioPharma, Inc. annual cash from operations year-on-year change?

Over the past year, ZBIO annual cash from operations has changed by -$89.14M (-292.00%)

What is Zenas BioPharma, Inc. quarterly cash from operations?

The current quarterly cash from operations of ZBIO is -$41.13M

What is the all-time high quarterly cash from operations for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high quarterly cash from operations is $31.85M

What is Zenas BioPharma, Inc. quarterly cash from operations year-on-year change?

Over the past year, ZBIO quarterly cash from operations has changed by -$10.07M (-32.41%)

What is Zenas BioPharma, Inc. TTM cash from operations?

The current TTM cash from operations of ZBIO is -$158.47M

What is the all-time high TTM cash from operations for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high TTM cash from operations is -$8.17M

What is Zenas BioPharma, Inc. TTM cash from operations year-on-year change?

Over the past year, ZBIO TTM cash from operations has changed by -$77.35M (-95.36%)
On this page